Hyperfractionated radiotherapy combined with a radiosensitizer may offer long-term disease-free survival in patients with unresectable primary cardiac sarcoma.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for unresectable cardiac sarcoma; prospective trials required before clinical adoption.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Movsas et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: